By Ahmed El-Medany Treatment with a ‘quadpill’ containing quarter doses of four antihypertensive drugs demonstrated better blood pressure control than initial monotherapy with full-dose irbesartan,…
View More Polypill beats monotherapy for hypertension: results from the QUARTET stud
Taken directly from European Heart Journal Many cardiac pacemakers and defibrillators are not approved by regulators for magnetic resonance imaging (MRI) which makes patient access…
View More Reducing barriers to MRI in patients with CIEDs
Taken directly from JACC Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with…
View More Percutaneous Coronary Revascularisation: Historical Breakthroughs
A Consensus StatementTaken directly from JAMA Network Open Question What leadership imperatives are most essential for health leaders following the emergency stages of the COVID-19…
View More Guidance for Health Care Leaders During the Recovery Stage of the COVID-19 Pandemic
By Ahmed El-Medany Presented by Professor Michele Brignole, San Luca Hospital, Milan, APAF-CRT was a two-phase trial in individuals with severely symptomatic atrial fibrillation (AF)…
View More Highlights from Day 2 of the ESC 2021 congress – APAF-CRT
By Ahmed El-Medany The 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) were published on the 27th of…
View More New 2021 ESC Guidelines for the diagnosis and management of heart failure published
By Saadia Aslam This expert consensus document reviews current insight into the underlying pathophysiology and available methods for assessing viability. In particular the document reviews…
View More Multimodality imaging of myocardial viability: An expert consensus document from the European Association of Cardiovascular Imaging (EACVI)
By Ahmed El-Medany One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For…
View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)
One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For those that were unable to attend, or for the sake of refreshing one’s memory, the following is a summary of all the trials presented…
View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)
overall, the results looked great. Hopefully, over the course of the next 12 months, we will finish recruitment for the final phase of the study to further confirm the primary safety and efficacy endpoints that we saw with the….
View More Novel pacing system improves clinical response in heart failure patients un-responsive to, or unsuitable for, cardiac resynchronisation therapy